She is not advocating for physicians to intentionally err on the side of an autism label, said Dr. Johnson, who disclosed that she had testified for the defense of vaccine manufacturers implicated in thimerosal lawsuits. Physicians must also weigh the possible negative consequences of labeling, particularly when the child might be on the mildest end of the spectrum. They also must look at the financial impact on early-intervention systems and school districts, she said.